DE69909257D1 - Verwendung von makroliden zur behandlung von akuten lungenverletzungen - Google Patents

Verwendung von makroliden zur behandlung von akuten lungenverletzungen

Info

Publication number
DE69909257D1
DE69909257D1 DE69909257T DE69909257T DE69909257D1 DE 69909257 D1 DE69909257 D1 DE 69909257D1 DE 69909257 T DE69909257 T DE 69909257T DE 69909257 T DE69909257 T DE 69909257T DE 69909257 D1 DE69909257 D1 DE 69909257D1
Authority
DE
Germany
Prior art keywords
macrolids
acute lung
treat acute
lung injuries
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69909257T
Other languages
English (en)
Other versions
DE69909257T2 (de
Inventor
Tadatsura Koshika
Itsuo Nagatomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE69909257D1 publication Critical patent/DE69909257D1/de
Application granted granted Critical
Publication of DE69909257T2 publication Critical patent/DE69909257T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE69909257T 1998-03-06 1999-03-04 Verwendung von makroliden zur behandlung von akuten lungenverletzungen Expired - Lifetime DE69909257T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP2231A AUPP223198A0 (en) 1998-03-06 1998-03-06 New use
AUPP223198 1998-03-06
PCT/JP1999/001064 WO1999044597A2 (en) 1998-03-06 1999-03-04 Use of macrolide compounds for the treatment of ards

Publications (2)

Publication Number Publication Date
DE69909257D1 true DE69909257D1 (de) 2003-08-07
DE69909257T2 DE69909257T2 (de) 2004-02-19

Family

ID=3806495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69909257T Expired - Lifetime DE69909257T2 (de) 1998-03-06 1999-03-04 Verwendung von makroliden zur behandlung von akuten lungenverletzungen

Country Status (15)

Country Link
US (1) US6333334B1 (de)
EP (1) EP1059921B1 (de)
JP (1) JP3367105B2 (de)
KR (1) KR100395571B1 (de)
CN (1) CN1133429C (de)
AT (1) ATE244008T1 (de)
AU (1) AUPP223198A0 (de)
BR (1) BR9908796A (de)
CA (1) CA2322027C (de)
DE (1) DE69909257T2 (de)
DK (1) DK1059921T3 (de)
ES (1) ES2196840T3 (de)
HK (1) HK1036406A1 (de)
PT (1) PT1059921E (de)
WO (1) WO1999044597A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
ES2399629T3 (es) * 2006-09-29 2013-04-02 Infa S.A. Sistema de acondicionamiento para composiciones farmacéuticas y kit para administración intravenosa
CA2673863A1 (en) * 2006-12-28 2008-07-10 Limerick Biopharma, Inc. Methods and compositions for therapeutic treatment
ES2435197T3 (es) 2007-01-10 2013-12-16 Board Of Regents, The University Of Texas System Administración mejorada de composiciones de fármacos inmunosupresores para la administración por vía pulmonar
CN101011414B (zh) * 2007-01-29 2010-07-21 褚福明 一种肺脑合剂药物
WO2009018338A2 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Phosphorylated pyrone analogs and methods
CN101810633B (zh) * 2010-03-31 2011-12-14 湖北丝宝药业有限公司 地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途
GB201212773D0 (en) * 2012-07-18 2012-08-29 Ucl Business Plc Vascular remodelling

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2248184A (en) * 1990-09-28 1992-04-01 Fujisawa Pharmaceutical Co New use of macrolide compounds for active oxygen-mediated diseases
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
AU8910891A (en) * 1990-11-20 1992-06-11 National Heart & Lung Institute, The Treatment of lung diseases
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5290689A (en) * 1992-09-28 1994-03-01 Merck & Co., Inc. New cyclic FR-900520 microbial biotransformation agent

Also Published As

Publication number Publication date
EP1059921B1 (de) 2003-07-02
AUPP223198A0 (en) 1998-04-02
CN1133429C (zh) 2004-01-07
KR100395571B1 (ko) 2003-08-21
ATE244008T1 (de) 2003-07-15
CN1292695A (zh) 2001-04-25
DK1059921T3 (da) 2003-10-27
JP3367105B2 (ja) 2003-01-14
EP1059921A2 (de) 2000-12-20
CA2322027A1 (en) 1999-09-10
PT1059921E (pt) 2003-11-28
US6333334B1 (en) 2001-12-25
WO1999044597A2 (en) 1999-09-10
DE69909257T2 (de) 2004-02-19
CA2322027C (en) 2009-05-12
HK1036406A1 (en) 2002-01-04
ES2196840T3 (es) 2003-12-16
KR20010041046A (ko) 2001-05-15
BR9908796A (pt) 2000-10-31
WO1999044597A3 (en) 1999-12-29
JP2001520682A (ja) 2001-10-30

Similar Documents

Publication Publication Date Title
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
TR200001203T2 (tr) Yeni birleşik maddeler
ATE251903T1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
DE69731473D1 (de) Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen
ATE228367T1 (de) Zusammensetzung zur prophylaxe und/oder behandlung von osteoporosis und änderungen durch menopausal-syndrom, enthaltend propionyl-l- carnitin und genistein
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
ATE287719T1 (de) Inhalierung von antiendotoxinmitteln zur vorbeugung oder behandlung von bakterieller lungeninfektion oder symptomatischer endotoxinaussetzung der lunge
DE69909257D1 (de) Verwendung von makroliden zur behandlung von akuten lungenverletzungen
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE283044T1 (de) Compactin zur behandlung von entzündungen
DE69914951D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE264309T1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60034110D1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE69504717T2 (de) Behandlung von organischen Verbindungen zur Reduzierung des Chlorgehaltes
DE69429013D1 (de) Verwendung von dimeticon zur behandlung der konstipation
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP